Nov. 28, 2020

Non-alcoholic fatty liver disease, NAFLD, is often talked about when we look at diabetes patients. Many studies have looked at the effects of NAFLD on patients with diabetes, and how this disease is a component of metabolic syndrome.

Unfortunately there are no ADA or AASLD guidelines for testing in type 2 patients, so oftentimes this test is not done. This week our South College Intern Shadrielle Robbins takes a look at a study that examines all possible combinations of testing in order to find out what is most cost effective; if the testing was worth the money spent on it; and if younger patients could benefit from testing sooner rather than later.

What she found out may totally surprise you.

 

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief